| Product Name | Bcl-3 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) antibody; |
| Product description | This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. |
| Immunogen | Synthesized peptide derived from human Bcl-3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHCWB |
| IHC:1:50-200 WB:1:500-1:2000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) antibody |
|---|---|
| Molecular Weight(MW) | 50 kDa |
| SwissProt ID | P20749 |
|---|
| Positive Control | Leukemia,Lung, |
|---|---|
| Application Notes | IHC:1:50-200 WB:1:500-1:2000 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
